FDA and CDC Virtual Press Conference: Johnson & Johnson COVID-19 Vaccine **Registration Required**
For Immediate Release: April 23, 2021
Contact: Media Relations
** FOR CREDENTIALED MEDIA ONLY **
As part of the FDA and CDC’s commitment to transparency, we invite you to join us for a virtual press conference via Zoom. This press conference will be live streamed over the FDA’s YouTube channel.
We ask you to join the Zoom virtual press conference with a camera so that the speakers may see you as you ask questions. Those reporters that ask questions will appear on the screen to the speakers and the public. Your image will also be broadcast via the FDA’s YouTube live stream.
A joint virtual press conference with the U.S. Centers for Disease Control and Prevention and the U.S. Food and Drug Administration to discuss the Johnson & Johnson (Janssen) COVID-19 Vaccine.
- Janet Woodcock, M.D., Acting FDA Commissioner
- Rochelle Walensky, M.D., CDC Director
- Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research
- Anne Schuchat, M.D., CDC Principal Deputy Director
WHEN: Fri., April. 23, 7:15 p.m. ET
WHERE: Registration is required to join the press conference – REGISTER
Registration is limited to credential media only and pre-registration is required this link:
**The confirmation email will contain the link to join the press conference via Zoom.**
For questions about the virtual press conference, please contact the FDA’s Office of Media Affairs at: firstname.lastname@example.org.
CDC works 24/7 protecting America’s health, safety and security. Whether disease start at home or abroad, are curable or preventable, chronic or acute, or from human activity or deliberate attack, CDC responds to America’s most pressing health threats. CDC is headquartered in Atlanta and has experts located throughout the United States and the world.